Historical record - last NADAC effective date: 1/1/2018
This NDC is on FDA's drug shortage list (posted Apr 26, 2023)
Reported reason: Other
Product Information
BICILLIN L-A 1,200,000 UNITS is a brand product labeled by Pfizer Inc., priced at $76.5188 per ML under NDC 60793070110. Its NADAC has been published 269 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is BC.
Strength
1200000 [iU]/2mL
Manufacturer
Pfizer Inc.NDC
60793070110
Classification
Brand
Dosage Form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Effective Date
1/1/2018
Active Ingredients
PENICILLIN G BENZATHINEApproval Type
New Drug (NDA)
FDA Application
NDA050141FDA Approved
Before 1982
TE Code
BC
On Market Since
6/27/1952
Pharmacological Classes
Price Statistics
The NADAC for BICILLIN L-A 1,200,000 UNITS has been published 269 times since Nov 28, 2013, and over the history we have for it it has risen 157.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $76.5188 per ML |
|---|---|
| All-time high | $76.5188 (Jan 16, 2019) |
| All-time low | $29.6739 (Nov 28, 2013) |
| Median price | $58.3768 |
| Average price | $55.7182 |
| Largest weekly change | +15.0% (Jan 8, 2014) |
| Weeks tracked | 269 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+157.9%
Last surveyed Jan 16, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the penicillin G benzathine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BICILLIN L-A 1,200,000 UNITS?
The current National Average Drug Acquisition Cost (NADAC) for BICILLIN L-A 1,200,000 UNITS, manufactured by Pfizer Inc., is $76.5188 per ML (NDC 60793070110), effective Jan 16, 2019.
How has the price of BICILLIN L-A 1,200,000 UNITS changed over time?
Over the history we have for it, the NADAC for BICILLIN L-A 1,200,000 UNITS has risen 157.9%. It has been tracked across 269 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BICILLIN L-A 1,200,000 UNITS?
Since Nov 28, 2013, the NADAC for BICILLIN L-A 1,200,000 UNITS has ranged from a low of $29.6739 (Nov 28, 2013) to a high of $76.5188 (Jan 16, 2019), with a median of $58.3768 per ML.
Are there cheaper alternatives to BICILLIN L-A 1,200,000 UNITS?
No other NADAC-published product currently shares the active ingredient and strength of BICILLIN L-A 1,200,000 UNITS in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BICILLIN L-A 1,200,000 UNITS?
BICILLIN L-A 1,200,000 UNITS (NDC 60793070110) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Is BICILLIN L-A 1,200,000 UNITS in shortage?
Yes — NDC 60793070110 is currently listed in FDA's drug shortage database (posted Apr 26, 2023). Reported reason: Other.